https://www.selleckchem.com/pr....oducts/suzetrigine.h
kely to be high in patients with COVID-19. Previous studies have illustrated the potential superiority of drug-coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous fistula (AVF) dysfunction due to stenosis. Our trial evaluated the efficacy and safety of DCBs for preventing fistula restenosis in Chinese hemodialysis patients. Multicenter, prospective, randomized, open-label, blinded end point, controlled trial. A total of 161 hemodialysis patients with fistula dysfunction from 10 centers in China.
Like
Comment
Share
